Semaglutide

Q: What does GLP-1 stand for?

GLP-1 stands for glucagon-like peptide-1, an incretin hormone secreted by intestinal L-cells in response to nutrient ingestion. It stimulates insulin secretion in a glucose-dependent manner.

Q: Why is semaglutide a popular research compound?

Semaglutide's long half-life, high GLP-1 receptor affinity, and well-characterized metabolic effects make it a frequently studied compound in preclinical metabolic research.

Q: What is the difference between semaglutide and tirzepatide?

Semaglutide is a single GLP-1 receptor agonist. Tirzepatide is a dual GIP/GLP-1 receptor agonist, targeting two incretin pathways simultaneously.

Semaglutide

Semaglutide (GLP-1 Receptor Agonist)

Research Use Only · Not for Human Consumption

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. It is an acylated peptide with a 94% sequence similarity to native human GLP-1. In research settings, semaglutide is used to study glucoregulation, insulin secretion, gastric emptying, and appetite signaling. Its fatty acid chain modification extends plasma half-life significantly compared to native GLP-1.

Key Facts

Sequence homology to GLP-1: 94%
Half-life (research models): ~7 days
Type: Acylated GLP-1 analog
Storage: -20°C lyophilized

Research Applications

Glucoregulation and insulin secretion studies
Appetite and satiety signaling research
Metabolic pathway modeling
Cardiovascular risk factor research
Fatty liver disease studies

Frequently Asked Questions

What does GLP-1 stand for?

Why is semaglutide a popular research compound?

What is the difference between semaglutide and tirzepatide?

Stock Semaglutide on Your Research Compound Store

PeptiCommerce provides turn-key access to COA-documented research compounds. Your branded WooCommerce store with P2P and crypto payment support, ready in under 72 hours.

Get Started →

Key Facts

Research Applications

Frequently Asked Questions

Related Terms

Get the Research Peptide Business Playbook